Résultats de la recherche
10
Tout
Rechercher les filtres
Mot-clé
als
Tiziana Life Sciences Files Investigational New Drug Application with FDA for ALS Phase 2 Clinical Trial
04 mars 2025 08h00 HE
|
Tiziana Life Sciences Ltd.
NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates
27 févr. 2025 16h05 HE
|
Athira Pharma, Inc.
Completed healthy volunteer Phase 1 clinical study of ATH-1105 as a potential treatment for amyotrophic lateral sclerosis (ALS) On-track to enable dosing ALS patients in 2025 BOTHELL, Wash., Feb. ...
Robert Califf, MD, MAAC, to Deliver Keynote Address at 2025 MDA Clinical & Scientific Conference
27 févr. 2025 09h00 HE
|
Muscular Dystrophy Association
New York, Feb. 27, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) announced today that Robert Califf, MD, MAAC, former Commissioner of the U.S. Food and Drug Administration and...
Muscular Dystrophy Association Launches Nation's Largest St. Patrick’s Day Fundraising Campaign Celebrating 75 Years of Progress
18 févr. 2025 15h27 HE
|
Muscular Dystrophy Association
New York, Feb. 18, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today launched the nation’s largest St. Patrick’s Day fundraising campaign, MDA Shamrocks, as part of its...
uniQure Announces Favorable Recommendation from Independent Data Monitoring Committee for its Phase I/II EPISOD1 Clinical Trial of AMT-162 for the Treatment of SOD1-ALS
30 janv. 2025 07h37 HE
|
uniQure Inc.
~ Independent Data Monitoring Committee Recommends Proceeding with Dose Escalation After Planned Safety Assessment of First Dose Cohort ~ ~ Company Expects to Initiate Enrollment of Second Dose...
MDA Launches 75th Anniversary Campaign and Premieres New PSA to Shine a Light on Rare Diseases
28 janv. 2025 09h00 HE
|
Muscular Dystrophy Association
New York, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) proudly announces the launch of its 75th anniversary campaign, marking a legacy of progress in research, care,...
The Sundogs to Host The Tom Petty Show at Variety Playhouse on 2/1, Supporting ALS Research
15 janv. 2025 11h20 HE
|
The Sundogs
ATLANTA, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Beloved local rock n’ roll band The Sundogs have announced their 12th annual Tom Petty Show, will be held Saturday, Feb. 1 at Variety Playhouse in the...
Tiziana Life Sciences Announces Review Article Published in Nature Highlighting Foralumab's Potential in the Treatment of Neurological Disease
08 janv. 2025 07h00 HE
|
Tiziana Life Sciences Ltd.
NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
Muscular Dystrophy Association and AFM-Téléthon Announce $510,000 Research Grant Awards Advancing Treatments for Mitochondrial Myopathies and ALS
18 déc. 2024 08h44 HE
|
Muscular Dystrophy Association
New York, Dec. 18, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) and AFM-Téléthon (the French muscular dystrophy association) are proud to announce the awarding of two...
Muscular Dystrophy Association Announces Over $5 Million in Research Grants to Advance Neuromuscular Disease Research
16 déc. 2024 08h42 HE
|
Muscular Dystrophy Association
New York, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) announced today the awarding of 21 new grants with a total funding commitment of over $5 million toward...